CliffBio
small molecule

MYKACET

NYSTATIN; TRIAMCINOLONE ACETONIDE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameMYKACET
Active ingredientNYSTATIN; TRIAMCINOLONE ACETONIDE
Strength100,000 UNITS/GM;0.1%
Dosage formOINTMENT
RouteTOPICAL
ModalitySmall molecule
FDA approvalMarch 1987
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.